INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,500 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$72K
197 sh
Jan 13, 2026
Page 1484 of 1813
← PrevNext →
Jan 14, 2026
traded Jan 13, 2026
+1d
SEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
6,700 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
6,700 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Grant or award
A—
19.0K sh
Jan 11, 2026Jan 14, 2026
traded Jan 11, 2026
+3dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
8,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$91K
8,000 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
5,400 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
PD
Papadopoulos DidierPresident of Aircraft OEM
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
804 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$94K
8,000 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

16
BP
Bodnar Dan PKChief Information Officer
SKWDSkyward Specialty Insurance Group, Inc.
Tax withholding
F$94K
2,049 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$104K
280 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
ML
Morgan Gerald L.Director, CEO, EXECUTIVE VICE CHAIRMAN
TXRHTexas Roadhouse, Inc.
Open-market sale · 10b5-1 plan
SELL$936K
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

15
SH
Spindel HowardDirector
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
PD
Perlysky DovDirector
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
MW
Michel Kirk WheelerDirector, Chairman
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
KL
Kao Lee10% Owner, General Manager
SCTHSecuretech Innovations, Inc.
Disposition to issuer
D—
2.60M sh
Jan 7, 2026Jan 14, 2026
traded Jan 7, 2026
+7dSEC Form 4

Evidence

15
KC
Krebs Mark C.Board Advisor
FMFGFarmers & Merchants Bancshares, Inc.
Grant or award
A$4,510
265 sh
Jan 8, 2026Jan 14, 2026
traded Jan 8, 2026
+6dSEC Form 4

Evidence

15
RS
Rosenthal Michael StuartChief Operating Officer
MPMP Materials Corp. / DE
Tax withholding
F$694K
10.6K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

15
WL
Wiesen Irving LDirector
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
KL
Kao Lee10% Owner, General Manager
SCTHSecuretech Innovations, Inc.
Grant or award
A—
260 sh
Jan 7, 2026Jan 14, 2026
traded Jan 7, 2026
+7dSEC Form 4

Evidence

15
CR
Corbett RyanChief Financial Officer
MPMP Materials Corp. / DE
Tax withholding
F$787K
12.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

15
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Small acquisition
L$1,067
100 sh
Dec 30, 2025Jan 14, 2026
traded Dec 30, 2025
+15dSEC Form 4

Evidence

15
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Small acquisition
L$53.6
5 sh
Jan 6, 2026Jan 14, 2026
traded Jan 6, 2026
+8dSEC Form 4

Evidence

15
RS
Rosenthal Michael StuartChief Operating Officer
MPMP Materials Corp. / DE
Tax withholding
F$580K
9,083 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

14
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Derivative conversion
C—
200.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
CP
Christian Darrianne PDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A$23K
397 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
JW
Juvenal Tobin WChief Commercial Officer
CSTLCASTLE BIOSCIENCES INC
Grant or award
A—
9,207 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
SM
Sabol MichaelVP - SEC and Financial Rprtng
VTSVitesse Energy, Inc.
Grant or award
A—
6,000 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

13
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$46K
122 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

13
AE
Allison EricChief Product Officer
JOBYJoby Aviation, Inc.
Option exercise
M—
53.5K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
MM
Morella MikeVP - Chief Accounting Officer
VTSVitesse Energy, Inc.
Grant or award
A—
6,000 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

13
KA
Kapadia Sandip AHead of Actuarial
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
AF
Abbasi FarazDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
650 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

13
HD
Hoops Elliot DeanGeneral Counsel and Secretary
MPMP Materials Corp. / DE
Grant or award
A—
8,722 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
CP
Christian Darrianne PDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
650 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

13
LD
Ling Geoffrey M.D.Director
CELUCelularity Inc
Grant or award
A—
19.2K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
BG
Birkenbeuel GaryDirector
TTEKTETRA TECH INC
Grant or award
A—
4,397 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
SF
Stokes FrankChief Financial Officer
CSTLCASTLE BIOSCIENCES INC
Grant or award
A—
8,124 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence